Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Q1 Trading Update

2 May 2007 07:00

Embargoed Release: 07:00hrs Wednesday 2nd May 2007

SOPHEON PLC ("Sopheon" or the "Company") TRADING UPDATE

Sopheon plc, the international provider of software and services that improve the financial return from innovation and product development investments issues a trading update. The first quarter of the year is traditionally quiet in the software business but we were pleased to record revenues 37% higher than in the first quarter of 2006. In addition to delivering license and service agreements secured in the prior year, we closed a further six license orders of which three were license extensions from existing customers. We also generated revenue from a number of new consultancy assignments. At the end of the first quarter, revenue visibility for the full year from contracted business and recurring revenue streams stood at ‚£3 million, added to which the potential of the sales pipeline remains very encouraging for the coming quarter and beyond. We would continue to emphasize that the timing and size of individual sales can cause variation in our reported results from period to period. Nevertheless, by the end of the first quarter 90 companies had licensed our software, and we expect this ongoing growth in the customer base to drive a rising pattern of repeat business, with continuing improvement in predictability over time.

In our 2006 preliminary statement we outlined our strategic priorities for the coming year. We are pleased to report progress on a range of fronts. As noted above, our customer base is delivering strong levels of repeat business. This is expected to continue, and is reinforced by an ongoing pattern of introducing our software into one or several business units within a large global company and expanding enterprise-wide over time. Customers signed in the first quarter all came from our target markets of chemicals, food and beverage, and consumer goods, as we deepen our market position in these segments. Our emerging relationship with Hewlett-Packard delivered a substantial services extension from the major auto customer we secured last year. Sopheon's initiative aimed at building productive partnerships with consulting firms continued to progress. New levels of interest and activity showed good promise of future sales as we furthered our work with strategic partners on a number of additional business opportunities. Some, like the auto customer, take us beyond traditional markets and territories.

Our product development team is continuing to move forward on its already well-advanced work on the next release of Accolade. At the same time, we are busily preparing for upcoming sessions of our European and North American Product Advisory Councils, which will convene in May. The council groups are comprised of executive-level decision-makers from some of the leading companies in the world, including BASF, Cadbury Schweppes, Campina, Celanese, Cytec, Electrolux, Hospira, Land O'Lakes, Nautilus, Nestle, Parker Hannifin, Verizon Wireless and Timex. A principal value of the impending meetings is that they will help us set market-driven priorities for the development of our Accolade product roadmap for 2008.

Over the last five years we have invested substantial resources in the development of our business, simultaneously driving for annual improvements in financial performance. This led to the achievement of positive EBITDA for the first time in 2006, making it a milestone year for Sopheon. We will continue to balance the needs of driving Sopheon forward strategically whilst staying focused on financial performance. We expect to maintain our established trend of advancement in 2007 and beyond.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel: +44 (0) 1483 685735 Arif Karimjee, CFO Sarah Wharry, Seymour Pierce Limited Tel: +44 (0) 207 107 8000 Nominated Adviser Andrew Tan Hansard Group Tel: +44 (0) 207 245 1100 +44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel: +31 (0) 205 754 010About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. The Sopheon Accolade‚® system automates gate or phase-based product development processes and provides strategic decision support that allows companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

SOPHEON PLC
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.